Publications

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas.

Castagna L

Bone Marrow Transplant. 2014 Sep 15;49(12):1475-80. doi: 10.1038/bmt.2014.197

Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma.

Grazia G

Cell Death Dis. 2014 Oct 2;5(10):e1434. doi: 10.1038/cddis.2014.410

Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases.

Guidetti A

Clin Cancer Res. 2014 Sep 19;20(22):5641-51. doi: 10.1158/1078-0432.CCR-14-0770

Role of alpha-synuclein in autophagy modulation of primary human T lymphocytes.

Colasanti T

Cell Death Dis. 2014 May 29;5(5):e1265. doi: 10.1038/cddis.2014.211

BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts.

Locatelli SL

Leukemia. 2014 Feb 24;28(9):1861-71. doi: 10.1038/leu.2014.81

Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.

Castagna L

Biol Blood Marrow Transplant. 2014 Feb 13;20(5):724-9. doi: 10.1016/j.bbmt.2014.02.001

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.

Magni M

Bone Marrow Transplant. 2014 Jan 20;49(4):485-91. doi: 10.1038/bmt.2013.214

Predictors of CD34+ cell mobilization and collection in adult men with germ cell tumors: implications for the salvage treatment strategy.

Necchi A

Clin Genitourin Cancer. 2013 Nov 13;12(3):196-202.e1. doi: 10.1016/j.clgc.2013.11.021

Plerixafor ‘on demand’: results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF.

Farina L

Bone Marrow Transplant. 2013 Dec 9;49(3):453-5. doi: 10.1038/bmt.2013.193

Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies.

Marconi M

Cell Death Dis. 2013 Oct 17;4(10):e863. doi: 10.1038/cddis.2013.389